T1	Participants 28 48	Huntington's disease
T2	Participants 238 272	patients with Huntington's disease
T3	Participants 282 329	Thirty three patients with Huntington's disease
T4	Participants 998 1084	Results of neuroleptic naive and neuroleptic treated patients were analysed separately
T5	Participants 889 946	Twelve patients already used other neuroleptic medication
T6	Participants 1880 1914	patients with Huntington's disease
